Medical Oncologist
Treatment costs
Pazopanib Price in India: — Brand, Generic and What to Expect
Pazopanib is available in India as the brand-name Votrient and as Indian-manufactured generics that cost substantially less. Knowing the price range before your first prescription helps you plan and ask the right questions at your pharmacy.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- Brand and generic both available — Pazopanib is sold as Votrient and under Indian generic names — the same active molecule at different price points.
- Monthly cost varies widely — The difference between brand and generic is significant for a drug you may take every day for months or years.
- Insurance may not cover it automatically — Many health policies exclude oral targeted therapies unless declared in advance — check before you pay out of pocket.
- Assistance schemes exist — Government programmes, hospital financial support and manufacturer access schemes can each reduce what you actually pay.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Pazopanib is available in India as the brand Votrient and as Indian-manufactured generics. At the standard daily dose, brand-name monthly costs are indicatively ₹75,000–1,10,000 (mid-2025). Indian generics are available at substantially lower prices. Ask your oncologist whether a generic is appropriate, and check your insurance policy before your first purchase.
How much does pazopanib cost per month in India?
| Option | Indicative monthly range (mid-2025) | Key point |
|---|---|---|
| Brand-name pazopanib (Votrient) | ₹75,000–1,10,000 | Retail price before any assistance; can be higher at some private hospital pharmacies |
| Indian-manufactured generic | ₹15,000–45,000 | Multiple manufacturers available; your oncologist can confirm which are CDSCO-approved |
| Under PMJAY or state government scheme | Covered or subsidised | Formulary inclusion and eligibility vary by state; confirm at an empanelled centre |
| With employer group or private insurance | Policy-dependent | Oral targeted therapies often require a declared rider; check your policy documents before assuming coverage |
Why is there such a large price difference between brand and generic pazopanib?
Generic versions become available when a drug's patent expires. Indian manufacturers apply to the CDSCO to produce and sell the same active molecule. The regulatory process confirms that the generic delivers the drug in the same way as the original.
The active molecule — pazopanib — is identical in the brand and any CDSCO-approved generic. The price difference reflects manufacturing economies and lower research and marketing overheads. It does not reflect a difference in the drug itself.
Your oncologist is the right person to advise whether an Indian generic is appropriate for you. Some people switch between brand and generic without any difficulty. In some clinical situations, an oncologist may prefer to keep a patient on the same product throughout for consistency.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Care closer to home
35+ centres, so most treatment does not mean relocating to a metro.
How do you get pazopanib at a lower cost?
Ask your oncologist about generics at your next appointment
Confirm whether an Indian-manufactured generic is suitable for you. Ask for the prescription to include the generic name, pazopanib, rather than a brand name only — this gives the pharmacist flexibility to dispense a lower-cost option.
Check your health insurance policy in writing
Look for clauses on oral targeted therapy or oral chemotherapy. Many group policies exclude these unless a specific rider was added at the time of purchase. If the language is unclear, ask your insurer in writing — a written confirmation is useful if you later need to make a claim.
Ask whether your hospital has a financial hardship programme
Many oncology centres have funds or arrangements that reduce costs for patients who would otherwise struggle to afford treatment. Ask the hospital social worker or patient navigator before paying out of pocket.
Check eligibility for PMJAY or your state government scheme
If you are eligible for Ayushman Bharat PMJAY or a state scheme, ask the hospital's empanelment desk whether pazopanib is on the covered formulary and what documents you need to bring.
Ask about manufacturer access programmes
Some pharmaceutical companies run patient assistance programmes for high-cost drugs. Your oncologist or the hospital pharmacy liaison is the first point of contact — these programmes are not usually accessible directly by patients.
What to check before you pay for pazopanib
- Confirm with your oncologist whether an Indian generic is appropriate before buying the brand
- Get a prescription that includes the generic name (pazopanib) so any pharmacy can dispense a suitable option
- Check your health insurance documents for oral targeted therapy exclusions before assuming you are covered
- Compare prices at the hospital pharmacy and a reputable retail pharmacy — the difference can be significant
- Ask the hospital social worker or patient navigator about hardship support before paying out of pocket
- Keep all pharmacy receipts and bills — they are needed for insurance reimbursement and income tax deduction under Section 80D
Explore 75 more Kidney, Ovarian & Sarcoma Targeted Medicines topics
Drug Deep Dive: Pazopanib (Votrient)
- Diarrhoea and Blood Pressure Rise on Pazopanib
- Diet and Nutrition While on Pazopanib
- Drug, Food and Supplement Interactions With Pazopanib
- Fertility, Pregnancy and Contraception on Pazopanib
- Hair Turning White and Skin Lightening on Pazopanib
- How Does Pazopanib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Pazopanib Take to Work?
- How Long Will You Stay on Pazopanib?
- Liver Toxicity on Pazopanib: Why LFTs Are Checked Every Two Weeks
- Pazopanib (Votrient, Pazonib): The Complete Patient Guide
- Pazopanib Combinations: Why It Is Usually Given Alone
- Pazopanib Myths: Hair Colour, Liver Damage and Stopping Early
- Pazopanib Price in India: Brand, Generic and Monthly Cost
- Pazopanib Side Effects: The Complete List and Timeline
- Pazopanib Success Rate and Survival: An Honest Look at the Numbers
- Pazopanib for Soft Tissue Sarcoma: What It Can and Cannot Do
- Pazopanib in Elderly Patients and Those With Other Illnesses
- Pazopanib in Kidney Cancer vs Sarcoma: Two Different Treatment Goals
- Pazopanib vs Sunitinib: Comparing Toxicity and Quality of Life
- Taking Pazopanib on an Empty Stomach: Why the Timing Rule Exists
- Tests and Monitoring While You Are on Pazopanib
- When Pazopanib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Pazopanib? Kidney Cancer and Soft Tissue Sarcoma
- Will Insurance or a Government Scheme Pay for Pazopanib?
- Work, Travel and Daily Life on Pazopanib
Drug Deep Dive: Olaparib (Lynparza)
- Adjuvant Olaparib After Early Breast Cancer Surgery
- Anaemia and Extreme Fatigue on Olaparib
- Blood Cancer Risk After Long-Term Olaparib: How Real Is It?
- Diet and Nutrition While on Olaparib
- Drug, Food and Supplement Interactions With Olaparib
- Fertility, Pregnancy and Contraception on Olaparib
- How Does Olaparib Work? The PARP Inhibitor Explained
- How Long Does Olaparib Take to Work?
- How Long Will You Stay on Olaparib?
- Maintenance Olaparib: Taking a Drug When There Is No Visible Cancer
- Nausea on Olaparib: Managing the Most Common Side Effect
- Olaparib (Lynparza, Olanib): The Complete Patient Guide
- Olaparib Myths: 'Only for BRCA', 'It's Chemo', 'It Causes Cancer'
- Olaparib Price in India: Brand, Generic and Monthly Cost
- Olaparib Side Effects: The Complete List and Timeline
- Olaparib Success Rate and Survival: An Honest Look at the Numbers
- Olaparib With Bevacizumab or Hormone Therapy: Combination Regimens
- Olaparib in Elderly Patients and Those With Other Illnesses
- Olaparib vs Niraparib vs Talazoparib: Comparing PARP Inhibitors
- Taking Olaparib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Olaparib
- When Olaparib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Olaparib? BRCA-Mutated Ovarian, Breast, Prostate and Pancreatic Cancer
- Will Insurance or a Government Scheme Pay for Olaparib?
- Work, Travel and Daily Life on Olaparib
Drug Deep Dive: Sunitinib (Sutent)
- Diet and Nutrition While on Sunitinib
- Drug, Food and Supplement Interactions With Sunitinib
- Fertility, Pregnancy and Contraception on Sunitinib
- Hand-Foot Skin Reaction on Sunitinib: Prevention From Day One
- How Does Sunitinib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Sunitinib Take to Work?
- How Long Will You Stay on Sunitinib?
- Mouth Sores, Taste Loss and Yellow Skin Discolouration on Sunitinib
- Sunitinib (Sutent, Sunitix): The Complete Patient Guide
- Sunitinib After Kidney Surgery and for GIST: Two Different Settings
- Sunitinib Myths: Hair Colour Change, Dose Cuts and 'Weaker Treatment'
- Sunitinib Price in India: Brand, Generic and Monthly Cost
- Sunitinib Side Effects: The Complete List and Timeline
- Sunitinib Success Rate and Survival: An Honest Look at the Numbers
- Sunitinib and Immunotherapy: Where Combinations Fit in Kidney Cancer
- Sunitinib in Elderly Patients and Those With Other Illnesses
- Sunitinib vs Pazopanib vs Cabozantinib for Kidney Cancer
- Taking Sunitinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Sunitinib
- The 4-Weeks-On, 2-Weeks-Off Sunitinib Schedule and the 2/1 Alternative
- Thyroid Failure and Fatigue on Sunitinib: The Test to Repeat Every Cycle
- When Sunitinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Sunitinib? Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumours
- Will Insurance or a Government Scheme Pay for Sunitinib?
- Work, Travel and Daily Life on Sunitinib
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Is generic pazopanib as effective as Votrient?
CDSCO-approved generic versions of pazopanib contain the same active molecule at the same strength. Regulatory approval requires the manufacturer to demonstrate bioequivalence — that the drug is absorbed and acts in the body in the same way as the reference product. Most oncologists are comfortable with CDSCO-approved generics. Ask your oncologist which manufacturers they are familiar with and whether they have any preference for your situation.
Does health insurance cover pazopanib in India?
It depends entirely on your policy. Group employer policies and individual policies often exclude oral targeted therapies by default, or require a declared rider or add-on. Some newer comprehensive cancer policies do cover them. Check your policy document for terms like 'oral chemotherapy', 'targeted therapy' or 'outpatient drug benefit'. If the language is unclear, ask your insurer in writing — a written confirmation is useful if you later need to make a claim.
Is pazopanib covered under Ayushman Bharat PMJAY?
PMJAY may cover pazopanib at empanelled hospitals, but inclusion depends on your state's formulary, the specific indication and your household eligibility. The empanelment desk at any PMJAY-empanelled hospital can check in real time whether your diagnosis and treatment are covered. Confirm this before stopping any other payment arrangement you have in place. Do not assume coverage — formularies change and differ significantly between states and empanelled centres.
Can I buy pazopanib online in India?
Licensed online pharmacies can dispense pazopanib against a valid prescription, as it is a Schedule H drug in India. Buying from unlicensed sources carries real risks: counterfeit medicine, incorrect strength, improper storage and no recourse if something goes wrong. Use a pharmacy that requires prescription verification and has a physical registered address. If cost is the concern driving you online, talk to your hospital team first — there may be a lower-cost option available through them.
How many tablets will I need per month?
Your monthly tablet count is set by the daily dose on your prescription, which your oncologist determines based on your weight, kidney function and how you tolerate the drug. Your pharmacist will dispense exactly that quantity. Buying a full month's supply at once, where possible, saves repeated trips and helps you stay consistent with treatment. Ask whether the pharmacy can source a full month's supply from the same batch.
Is there a patient assistance programme for pazopanib in India?
Some pharmaceutical companies operating in India run named patient programmes or compassionate use schemes for high-cost medicines. These are typically accessed through your treating oncologist rather than directly by you. At CION, the oncology team can advise on current access programmes relevant to your treatment and help coordinate the process. Ask at your next appointment — availability and eligibility change, so a current check through your team is more reliable than anything you read online.